AI Summary
Thinking
We reviewed 3 live results for tumor microarrays and narrowed them down to the 3 options that look most worth comparing first.
The options are Intraocular Tumor and Plaque Brachytherapy Service, Human Microarrays - GenetiSure Cyto CGH Microarrays and Preclinical Histology & IHC Services.
Source: Singapore National Eye Centre
Description
Singapore National Eye Centre provides the Intraocular Tumor and Plaque Brachytherapy Service for patients with abnormal growths inside the eye, including uveal melanoma, retinoblastoma, and vascular tumors. The service offers comprehensive eye examinations, advanced diagnostic imaging, pathology support, surgical interventions, and targeted plaque brachytherapy radiation therapy to control tumors while preserving vision and eye health.
Best for
Patients with intraocular eye tumors, Patients diagnosed with uveal or choroidal melanoma, Specialized diagnostic evaluation of eye tumors and Targeted radiation treatment via plaque brachytherapy
Rate this product
Source: PT. Elo Karsa Utama
Description
Agilent GenetiSure Cyto CGH Microarrays provide specialized CGH and CGH+SNP microarray designs for cytogenetic workflows, offered in Indonesia through distributor PT Elo Karsa Utama. Built for clinical and research laboratories, these human microarrays detect copy number variations and copy-neutral loss of heterozygosity in constitutional DNA samples extracted from blood, saliva, amniotic fluid, or CVS. Available in 4x180K and 8x60K formats utilizing SurePrint technology, they target disease-associated regions linked to developmental delay, intellectual disability, neuropsychiatric disorders, and congenital anomalies.
Best for
Cytogenetic research laboratories, Clinical genetics laboratories, Detection of copy number variations (CNV) and loss of heterozygosity (cnLOH) and Prenatal and postnatal cytogenetic research
Rate this product
Source: Champions Oncology
Description
Champions Oncology provides comprehensive preclinical histology and immunohistochemistry (IHC) services to support oncology research and drug development. Offerings include tissue collection, processing, FFPE generation, H&E staining, biomarker optimization, custom tumor tissue microarrays (TMAs), and quantitative slide digitization. Supported by board-certified pathologists and GCLP-compliant laboratories, these services deliver high-quality target expression analysis and histopathology endpoints for PDX models, in vivo and ex vivo studies, and clinical trial sample evaluation.
Best for
Oncology researchers, Preclinical drug development teams, Evaluating target biomarker expression in tumor tissues and Selecting and analyzing PDX and TumorGraft models
Rate this product
| Compare | #1Intraocular Tumor and Plaque Brachytherapy Service | #2Human Microarrays - GenetiSure Cyto CGH Microarrays | #3Preclinical Histology & IHC Services |
|---|---|---|---|
| Source | Singapore National Eye Centre | PT. Elo Karsa Utama | Champions Oncology |
| Description | Singapore National Eye Centre provides the Intraocular Tumor and Plaque Brachytherapy Service for patients with abnormal growths inside the eye, including uveal melanoma, retinoblastoma, and vascular tumors. The service offers comprehensive eye examinations, advanced diagnostic imaging, pathology support, surgical interventions, and targeted plaque brachytherapy radiation therapy to control tumors while preserving vision and eye health. | Agilent GenetiSure Cyto CGH Microarrays provide specialized CGH and CGH+SNP microarray designs for cytogenetic workflows, offered in Indonesia through distributor PT Elo Karsa Utama. Built for clinical and research laboratories, these human microarrays detect copy number variations and copy-neutral loss of heterozygosity in constitutional DNA samples extracted from blood, saliva, amniotic fluid, or CVS. Available in 4x180K and 8x60K formats utilizing SurePrint technology, they target disease-associated regions linked to developmental delay, intellectual disability, neuropsychiatric disorders, and congenital anomalies. | Champions Oncology provides comprehensive preclinical histology and immunohistochemistry (IHC) services to support oncology research and drug development. Offerings include tissue collection, processing, FFPE generation, H&E staining, biomarker optimization, custom tumor tissue microarrays (TMAs), and quantitative slide digitization. Supported by board-certified pathologists and GCLP-compliant laboratories, these services deliver high-quality target expression analysis and histopathology endpoints for PDX models, in vivo and ex vivo studies, and clinical trial sample evaluation. |
| Best for | Patients with intraocular eye tumors, Patients diagnosed with uveal or choroidal melanoma, Specialized diagnostic evaluation of eye tumors and Targeted radiation treatment via plaque brachytherapy | Cytogenetic research laboratories, Clinical genetics laboratories, Detection of copy number variations (CNV) and loss of heterozygosity (cnLOH) and Prenatal and postnatal cytogenetic research | Oncology researchers, Preclinical drug development teams, Evaluating target biomarker expression in tumor tissues and Selecting and analyzing PDX and TumorGraft models |
| Action | Singapore National Eye Centre | PT. Elo Karsa Utama | Champions Oncology |
| Rate this product |
"Intraocular Tumor and Plaque Brachytherapy Service from Singapore National Eye Centre."
Note: TopFind AI compiles product and service information for general comparison purposes only.